Oncogenic Signaling Pathways in The Cancer Genome Atlas

Sanchez-Vega, Francisco, Mina, Marco, Armenia, Joshua, Chatila, Walid K., Luna, Augustin, La, Konnor C., Dimitriadoy, Sofia, Liu, David L. +771 more·2018·Cell
DOI 10.1016/j.cell.2018.03.035

Cited by (1,006)

Items 701–800 of 1,006

  1. Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer
    Dominic Leiser, Santanu Samanta, John Gordon Eley, J Strauss, Michael Creed, Tami J. Kingsbury, Paul N. Staats, Binny Bhandary, Minjie Chen, Tijana Đukić et al. · 2021 · PLoS ONE
  2. Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing
    Yi‐Hua Jan, Kien Thiam Tan, Shu‐Jen Chen, Timothy Tak Chun Yip, Cu‐Tai Lu, Alfred King-yin Lam · 2022 · British Journal of Cancer
  3. Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting
    Ashna Gupta, Gunjan Dagar, Ravi Chauhan, Hana Q. Sadida, Sara K. Al-Marzooqi, Sheema Hashem, Shahab Uddin M.S., Muzafar Ahmad Macha, Ammira S. Al-Shabeeb Akil, Tej Krishan Pandita et al. · 2023 · Advances in protein chemistry and structural biology
  4. Recent advances of data‐independent acquisition mass spectrometry‐based proteomics
    Tiannan Guo, Ruedi H. Aebersold · 2023 · PROTEOMICS
  5. Attention-based GCN integrates multi-omics data for breast cancer subtype classification and patient-specific gene marker identification
    Hui Guo, Xiang Lv, Yizhou Li, Menglong Li · 2023 · Briefings in Functional Genomics
  6. Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency
    Jong‐Wan Kwon, Jeong-Seop Oh, Sang Hyeok Seok, Hyeok‐Won An, Yu Jin Lee, Na Yun Lee, Taehun Ha, Hyeon Ah Kim, Gyeong Min Yoon, Sung Eun Kim et al. · 2023 · Molecular Cancer
  7. K-nearest-neighbor algorithm to predict the survival time and classification of various stages of oral cancer: a machine learning approach
    Rashmi Siddalingappa, K. Sekar · 2023 · F1000Research
  8. ALYREF promotes the metastasis of nasopharyngeal carcinoma by increasing the stability of NOTCH1 mRNA
    Ya‐Nan Jin, Ji‐Jin Yao, Jianchang Fu, Qitao Huang, Yilin Luo, Yafei You, Wangjian Zhang, Qian Zhong, Tianliang Xia, Liangping Xia · 2024 · Cell Death and Disease
  9. Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma
    Kuniaki Sato, Farhoud Faraji, Rodolfo Daniel Cervantes‐Villagrana, Xingyu Wu, Keiichi Koshizuka, Tomohiko Ishikawa, Ramiro Iglesias‐Bartolomé, Lei Chen, Paula L. Miliani de Marval, Stephen L. Gwaltney et al. · 2025 · Cancer Letters
  10. Equitable machine learning counteracts ancestral bias in precision medicine
    Leslie A. Smith, James A. Cahill, Ji‐Hyun Lee, Kiley S. Graim · 2025 · Nature Communications
  11. Role of the oral-gut microbiota axis in pancreatic cancer: a new perspective on tumor pathophysiology, diagnosis, and treatment
    Xuanchi Guo, Yuhan Shao · 2025 · Molecular Medicine
  12. Three-dimensional genome landscape of primary human cancers
    Kathryn E. Yost, Yan-Ding Zhao, King L. Hung, Kai-Yuan Zhu, Duo Xu, M. Corces, Shadi Shams, Brian H Louie, Shahab Sarmashghi, Laksshman Sundaram et al. · 2025 · Nature Genetics
  13. Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect
    Sheng Wang, Dexi Zhou, Zhenyu Xu, Jing Song, Xueyi Qian, Xiongwen Lv, Jiajie Luan · 2019 · Current Drug Targets
  14. Systems Biology Understanding of the Effects of Lithium on Cancer
    Weihao Ge, Eric Jakobsson · 2019 · Frontiers in Oncology
  15. Spontaneous Tumor Regression in Tasmanian Devils Associated with RASL11A Activation
    Mark J. Margres, Manuel Ruiz‐Aravena, Rodrigo Hamede, Kusum Chawla, Austin H. Patton, Matthew F. Lawrance, Alexandra K. Fraik, Amanda R. Stahlke, Brian W. Davis, Elaine A. Ostrander et al. · 2020 · Genetics
  16. The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma
    Xiulei Zhang, Peiming Zheng, Zhen Li, Shanjun Gao, Guangzhi Liu · 2020 · OncoTargets and Therapy
  17. Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma
    Siwei Wang, Mulong Du, Jingyuan Zhang, Weizhang Xu, Qianyu Yuan, Ming Li, Jie Wang, Hongyu Zhu, Yuzhuo Wang, Cheng Wang et al. · 2020 · Nature Communications
  18. Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma
    Takuma Nakatsuka, Hayato Nakagawa, Yuki Hayata, Taijiro Wake, Tomoharu Yamada, Mizuki Nishibatake Kinoshita, Ryo Nakagomi, Masaya Sato, Tatsuya Minami, Koji Uchino et al. · 2021 · Journal of Gastroenterology
  19. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
    Aurélie Moreira, Arthur Poulet, Julien Masliah‐Planchon, Charlotte Lecerf, Sophie Vacher, Linda Larbi Chérif, Célia Dupain, Grégoire Marret, Elodie Girard, Laurène Syx et al. · 2021 · ESMO Open
  20. Network-based protein-protein interaction prediction method maps perturbations of cancer interactome
    Jiajun Qiu, Kui Chen, Chunlong Zhong, Sihao Zhu, Xiao Ma · 2021 · PLoS Genetics
  21. Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
    Rafael S. Rios, Kenneth I. Zheng, Ming-Hua Zheng · 2021 · Chinese Medical Journal
  22. Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers
    Solip Park, Fran Supek, Ben Lehner · 2021 · Nature Communications
  23. Shooting at Moving and Hidden Targets—Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas
    Joanna Kałafut, Arkadiusz Czerwonka, Alinda Anameriç, Alicja Przybyszewska-Podstawka, Julia Oliwia Misiorek, Adolfo Rivero‐Müller, Matthias Nees · 2021 · Cancers
  24. CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma
    Minghui Zhang, Jianli Ma, Qiuyue Guo, Shuang Ding, Yan Wang, Haihong Pu · 2022 · Frontiers in Immunology
  25. 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
    Jiheng Zhang, Nan Wang, Jiasheng Wu, Xin Gao, Hongtao Zhao, Zhihui Liu, Xiuwei Yan, Jiawei Dong, Fang Wang, Yixu Ba et al. · 2022 · Frontiers in Immunology
  26. Identification and Verification of m7G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma
    Kai Dong, Di Gu, Jiazi Shi, Yewei Bao, Zhibin Fu, Yu Fang, Le Qu, Wentong Zhu, Aimin Jiang, Linhui Wang · 2022 · Frontiers in Immunology
  27. Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
    Sirajudheen Anwar, Jonaid Ahmad Malik, Sakeel Ahmed, Verma Abhishek Kameshwar, Jowaher Alanazi, Abdulwahab Alamri, Nafees Ahemad · 2022 · Molecules
  28. NF1 alterations in cancers: therapeutic implications in precision medicine
    Jean-Stéphane Giraud, Ivan Bièche, Éric Pasmant, Camille Tlemsani · 2023 · Expert Opinion on Investigational Drugs
  29. Facile synthesis of aquo-cisplatin arsenite multidrug nanocomposites for overcoming drug resistance and efficient combination therapy
    Jingyu Xin, Ke Zhang, Jiaqi Huang, Xiangjie Luo, Xuanqing Gong, Zhaoxuan Yang, Hongyu Lin, Hong Shan, Jinhao Gao · 2018 · Biomaterials Science
  30. Macrophage Migration and Phagocytosis Are Controlled by Kindlin-3's Link to the Cytoskeleton
    Huan Liu, Liang Zhu, Tejasvi Dudiki, Benjamin Gabanic, Logan Good, Eugene A. Podrez, Olga A. Cherepanova, Jun Qin, Tatiana V. Byzova · 2020 · The Journal of Immunology
  31. Predicting Tumor Cell Response to Synergistic Drug Combinations Using a Novel Simplified Deep Learning Model
    Heming Zhang, Jiarui Feng, Amanda Zeng, Philip Payne, Fuhai Li · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells
    Hoffmann, Michèle J., Meneceur, Sarah, Hommel, Katrin, Schulz, Wolfgang A., Niegisch, Günter · 2021 · Genes
  33. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway
    Tao Li, Yujie Li · 2022 · Immunobiology
  34. Radiogenomics and machine learning predict oncogenic signaling pathways in glioblastoma
    Abdul Basit Ahanger, Syed Wajid Aalam, Tariq Masoodi, Asma Shah, Meraj Alam Khan, Ajaz Ahmad Bhat, Assif Assad, Muzafar Ahmad Macha, Muzafar Rasool Bhat · 2025 · Journal of Translational Medicine
  35. Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer
    Md Sadique Hussain, Prasanna Srinivasan Ramalingam, Gayathri Chellasamy, Kyusik Yun, Ajay Singh Bisht, Gaurav Gupta · 2025 · Clinical Breast Cancer
  36. The KEAP1-Cullin3-RBX1-Nrf2 Axis in Redox Homeostasis: Molecular Mechanisms, Pathophysiological Roles, and Precision Therapeutic Opportunities
    Mayank Attri, Omkar Kumar Kuwar · 2025 · Molecular Neurobiology
  37. Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future Perspectives
    Diane Qiao, Richard C. Wang, Zhixiang Wang · 2025 · Cells
  38. Cell adhesion-related gene somatic mutations are enriched in aggressive papillary thyroid microcarcinomas
    Jianlu Song, Shouxin Wu, Xiaotian Xia, Yu Wang, Youben Fan, Zhili Yang · 2018 · Journal of Translational Medicine
  39. Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
    Taha Azad, Reza Rezaei, Abera Surendran, Ragunath Singaravelu, Stephen Boulton, Jaahnavi Dave, John Cameron Bell, Carolina S. Ilkow · 2020 · Cancers
  40. Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations
    Gahyun Kim, Jin-Ho Kim, Hongui Cha, Woong‐Yang Park, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Yongjin Park, Joon Young Choi, Kyung-Han Lee et al. · 2020 · Scientific Reports
  41. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases
    Yoshikuni Kawaguchi, Timothy Eric Newhook, Hop S. Tran Cao, Ching-Wei David Tzeng, Yun Shin Chun, Thomas A. Aloia, Arvind N. Dasari, Scott Kopetz, Jean‐Nicolas Vauthey · 2020 · Journal of Gastrointestinal Surgery
  42. Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma
    Xuewen Liu, Fang Wang, C. Xu, Xinru Chen, Xue Hou, Qian Li, Pansong Li, Zhi Xie, Yongdong Liu, Lianpeng Chang et al. · 2020 · Oncogene
  43. Multi-Approach Bioinformatics Analysis of Curated Omics Data Provides a Gene Expression Panorama for Multiple Cancer Types
    Bruno César Feltes, Joice de Faria Poloni, Itamar José Guimarães Nunes, Sara Socorro Faria, Márcio Dorn · 2020 · Frontiers in Genetics
  44. Getting a Grip on the Undrugged: Targeting β‐Catenin with Fragment‐Based Methods
    Dirk Kessler, Moriz Mayer, Stephan K. Zahn, Markus Zeeb, Simon Wöhrle, Andreas Bergner, Jens Bruchhaus, Tuncay Ciftci, Georg Dahmann, Maike Dettling et al. · 2020 · ChemMedChem
  45. The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
    Narasimha Murthy Beeraka, Venugopal Reddy Bovilla, Shalini H. Doreswamy, Sujatha Puttalingaiah, Asha Srinivasan, SubbaRao V. Madhunapantula · 2021 · Cancers
  46. Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients
    Hainan Li, Changguo Shan, Shengnan Wu, Baijie Cheng, Chongzu Fan, Linbo Cai, Yedan Chen, Yuqian Shi, Kaihua Liu, Yang Washington Shao et al. · 2021 · Frontiers in Oncology
  47. SNORA23 inhibits HCC tumorigenesis by impairing the 2'-O-ribose methylation level of 28S rRNA
    Zhiyong Liu, Yanan Pang, Yin Hua Jia, Qin Qin, Rui Wang, Wei Li, Jing Jie, Haidong Liu, Shanrong Liu · 2021 · Cancer Biology and Medicine
  48. SOCS2 is a potential prognostic marker that suppresses the viability of hepatocellular carcinoma cells
    Jiankun Liu, Zhiyong Liu, Wei Li, Shurong Zhang · 2021 · Oncology Letters
  49. A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles
    Rileen Sinha, Augustin Luna, Nikolaus D. Schultz, Chris Sander · 2021 · Cell Reports Methods
  50. Hyaluronic Acid-Modified Nanoparticles Self-Assembled from Linoleic Acid-Conjugated Chitosan for the Codelivery of miR34a and Doxorubicin in Resistant Breast Cancer
    Xiaoxia Yang, Pengfei Shang, Jianbo Ji, Christina Vallen Malichewe, Zhiyin Yao, Jing Liao, Dandan Du, Chao Sun, Lei Wang, Ya-jie Tang A et al. · 2021 · Molecular Pharmaceutics
  51. Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
    Annika Nelde, Lea Flötotto, Lara Jürgens, Laura Szymik, Elvira Hubert, Jens Bauer, Christoph Schliemann, Torsten Keßler, Georg Lenz, Hans‐Georg Rammensee et al. · 2022 · Cellular and Molecular Life Sciences
  52. Oncogenic Pathways in Neurodegenerative Diseases
    Luis Varela, María E.R. García-Rendueles · 2022 · International Journal of Molecular Sciences
  53. Targeting DEAD ‐box RNA helicases: The emergence of molecular staples
    Sai Kiran Naineni, Francis Robert, Bhushan Nagar, Jerry Pelletier · 2022 · Wiley Interdisciplinary Reviews - RNA
  54. Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling
    Hongxing Shen, Fengyuan Huang, Xiangmin Zhang, Oluwagbemiga A. Ojo, Yuebin Li, Hoa Quang Trummell, Joshua Charles Anderson, John B. Fiveash, Markus Bredel, Eddy Shih-Hsin Yang et al. · 2022 · Nature Communications
  55. Identification of novel Pyrrolo[2,3-d]Pyrimidine-based KRAS G12C inhibitors with anticancer effects
    Zhendong Song, Linlin Lou, Guangjin Fan, Lu Liu, Ge Yang, He Liu, Albert S. C. Chan, Xiaolei Zhang, Xiao‐Feng Xiong · 2022 · European Journal of Medicinal Chemistry
  56. Spatial promoter–enhancer hubs in cancer: organization, regulation, and function
    Zhao, Jingru, Faryabi, Robert B. · 2023 · Trends in Cancer
  57. Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity
    Harit Panda, Mikiko Suzuki, Mitsuru Naito, Ritsumi Saito, Huaichun Wen, Liam Baird, Akira Uruno, Kanjiro Miyata, Masayuki P. Yamamoto · 2022 · Free Radical Biology and Medicine
  58. Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
    Chen Xue, Xinyu Gu, Yalei Zhao, Junjun Jia, Qiuxian Zheng, Yuanshuai Su, Zhengyi Bao, Juan Lu, Lanjuan Li · 2022 · Cancer Cell International
  59. Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma
    Daniel Boiarsky, Christine Lydon, Emily S. Chambers, Lynette Marie Sholl, Mizuki Nishino, Ferdinandos Skoulidis, John Victor Heymach, Junhang Luo, Mark Magdi Awad, Pasi Antero Janne et al. · 2023 · Annals of Oncology
  60. Robinin inhibits pancreatic cancer cell proliferation, EMT and inflammation via regulating TLR2-PI3k-AKT signaling pathway
    Wenwen Zhang, Wenting Liu, Xingchen Hu · 2023 · Cancer Cell International
  61. Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants
    Nicolina Jovanovich, Ahmed Habib, Akanksha Sri Satya Chilukuri, N. U. Farrukh Hameed, Hansen Deng, Regan Mary Shanahan, Jeffrey R. Head, Pascal Olivier Zinn · 2024 · Frontiers in Oncology
  62. Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and FOXA1 in liver cancer cells
    S. Nakagawa, Kiyoshi Yamaguchi, Kiyoko Takane, Sho Tabata, T. Ikenoue, Yoichi Furukawa · 2024 · Communications Biology
  63. Gut microbiota and their influence in brain cancer milieu
    Bandari BharathwajChetty, Aviral Kumar, Pranav I. Deevi, Mohamed Abbas, Athba Alqahtani, Liping Liang, Gautam Sethi, Le Liu, Ajaikumar Bahulayan Kunnumakkara · 2025 · Journal of Neuroinflammation
  64. Statistical genomics in rare cancer
    Farnoosh Abbas Aghababazadeh, Qianxing Mo, Brooke L. Fridley · 2019 · Seminars in Cancer Biology
  65. Pathway Mutations in Breast Cancer Using Whole-Exome Sequencing
    Ya‐Sian Chang, Chieh‐Min Chang, Chien‐Yu Lin, Dysan Chao, Hsi‐Yuan Huang, Jan‐Gowth Chang · 2019 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  66. SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
    Ruoyan Liu, Yanjie Shuai, Jingtao Luo, Ze Zhang · 2019 · Frontiers in Oncology
  67. TASK-3 Gene Knockdown Dampens Invasion and Migration and Promotes Apoptosis in KATO III and MKN-45 Human Gastric Adenocarcinoma Cell Lines
    Rocio Cikutović-Molina, Andrés A. Herrada, Wendy González, Nelson E. Brown, Leandro Zúñiga · 2019 · International Journal of Molecular Sciences
  68. Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing
    You Jin Chun, Jae Woo Choi, Min Hee Hong, Dongmin Jung, Hyeonju Son, Eun Kyung Cho, Young Joo Min, Sang‐We Kim, Keunchil Park, Sung Sook Lee et al. · 2019 · PLoS ONE
  69. Econazole Induces p53-Dependent Apoptosis and Decreases Metastasis Ability in Gastric Cancer Cells
    Eun Kyoung Choi, Eun Jung Park, Tien Thuy Phan, Hea Dong Kim, Kwang‐Lae Hoe, Dong-Uk Kim · 2020 · Biomolecules & Therapeutics
  70. Metformin: (future) best friend of the radiation oncologist?
    Benjamin Chevalier, Dominique Pasquier, Eric Felix Lartigau, Cyrus Chargari, Antoine Schernberg, Arnaud Jannin, Xavier Mirabel, Marie‐Christine Vantyghem, Alexandre Escande · 2020 · Radiotherapy and Oncology
  71. Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML
    Hidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, Yutarou Harata, Moe Higashitani, Yuri Ito, Yasuhiko Kamikubo, Yusuke Shiozawa, Yuichi Shiraishi, Kenichi Chiba et al. · 2020 · Blood Advances
  72. Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis
    Alireza Tabibzadeh, Fahimeh Safarnezhad Tameshkel, Yousef Moradi, Saber Soltani, Maziar Moradi‐Lakeh, Gholam Hossein Ashrafi, Nima Motamed, Farhad Zamani, Seyed Abbas Motevalian, Mahshid Panahi et al. · 2020 · Scientific Reports
  73. Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS–MAPK pathway and TP53 as potential predictors of immunotherapy efficacy
    Jingyuan Wang, Joanne Xiu, Yasmine Baca, Hiroyuki Arai, Francesca Battaglin, Natsuko K. Kawanishi, Shivani Soni, Wenjing Zhang, Joshua Millstein, Anthony Frank Shields et al. · 2021 · Annals of Oncology
  74. Bone marrow mesenchymal stem cells promote prostate cancer cell stemness via cell–cell contact to activate the Jagged1/Notch1 pathway
    Jiwen Cheng, Li-xia Duan, Yang Yu, Pu Wang, Jiale Feng, G.Z. Feng, Yan Liu · 2021 · Cell & Bioscience
  75. Remodeling Chondroitin-6-Sulfate–Mediated Immune Exclusion Enhances Anti–PD-1 Response in Colorectal Cancer with Microsatellite Stability
    Qijing Wu, Qiong Huang, Yu Jiang, Fei Sun, Bishan Liang, Jiao Wang, Xingbin Hu, Mengting Sun, Zhenfeng Ma, Yulu Shi et al. · 2021 · Cancer Immunology Research
  76. The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
    Xuefei Jiang, Lanlan Yang, Qianling Gao, Yiting Liu, Xingzhi Feng, Shubiao Ye, Zihuan Yang · 2022 · Frontiers in Genetics
  77. Comprehensive Analysis of the Carcinogenic Process, Tumor Microenvironment, and Drug Response in HPV-Positive Cancers
    Xiaorong Yu, Jiankai Xu, Dahua Xu, Xiaoman Bi, Hong Wang, Yanda Lu, Meng Cao, Wenxiang Wang, Zhizhou Xu, Dehua Zheng et al. · 2022 · Frontiers in Oncology
  78. Visual barcodes for clonal-multiplexing of live microscopy-based assays
    Tom Kaufman, Erez Nitzan, Nir Firestein, Miriam Bracha Ginzberg, Seshu Iyengar, Nish Patel, Rotem Ben‐Hamo, Ziv Porat, Jaryd Hunter, Andreas Hilfinger et al. · 2022 · Nature Communications
  79. The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications
    Diana Giannuzzi, Laura Marconato, Antonella Fanelli, Luca Licenziato, Raffaella De Maria, Andrea Rinaldi, Luca Rotta, Nicole Rouquet, Giovanni Birolo, Piero Fariselli et al. · 2022 · Lab Animal
  80. How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?
    Yulia Kirdeeva, Olga Fedorova, Alexandra A. Daks, Nickolai A. Barlev, Oleg Y. Shuvalov · 2022 · Pharmaceuticals
  81. Integration of androgen hormones in endometrial cancer biology
    Marija Gjorgoska, Tea Lanišnik Rižner · 2022 · Trends in Endocrinology and Metabolism
  82. Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
    Jing Yu, Xi Wu, Jinen Song, Yujie Zhao, Huifang Li, Min Luo, Xiaowei Liu · 2022 · Frontiers in Pharmacology
  83. Transcription Factor Sp1 in the Expression of Genes Encoding Components of Mapk, JAK/STAT, and PI3K/Akt Signaling Pathways
    Karina A. Ivanenko, Vladimir Prassolov, Elmira Khabusheva · 2022 · Molecular Biology
  84. Genetic dysregulation of immunologic and oncogenic signaling pathways associated with tumor-intrinsic immune resistance: a molecular basis for combination targeted therapy-immunotherapy for cancer
    Kristian Michael Hargadon · 2023 · Cellular and Molecular Life Sciences
  85. PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types
    Pei Ling Chia, Koon Hwee Ang, Min Thura, Qi Zeng · 2023 · Theranostics
  86. Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells
    Deen, Ashik Jawahar, Adinolfi, Simone, Härkönen, Jouni, Patinen, Tommi, Liu, Xiaonan, Laitinen, Tuomo, Takabe, Piia, Kainulainen, Kirsi, Pasonen-Seppänen, Sanna, Gawriyski, Lisa M. et al. · 2024 · Redox Biology
  87. Prognostic Role of KRAS mRNA Expression in Breast Cancer
    Ki‐Tae Hwang, Byoung Hyuck Kim, Sohee Oh, So Yeon Park, Jiwoong Jung, Jong-Jin Kim, In Sil Choi, Sook Young Jeon, Woo‐Young Kim · 2019 · Journal of Breast Cancer
  88. Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy
    Zhe Zhao, Shufen Xiang, Jindan Qi, Yijun Wei, Mengli Zhang, Jun Yao, Tong Zhang, Mei Meng, Xiaohua Wang, Quansheng Zhou · 2020 · Cell Death and Disease
  89. Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression
    Zhenduo Shi, Xiao-Xiao Han, Zijian Song, Yang Dong, Kun Pang, Xin-Lei Wang, Xinyu Liu, Hao Xin Lu, Guangzhi Xu, Lin Hao et al. · 2023 · Biomarker Research
  90. Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
    Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bo-Hwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed Omar Kaseb et al. · 2024 · Clinical and Molecular Hepatology
  91. GBM immunotherapy: Exploring molecular and clinical frontiers
    Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, Sayani Ghosh, Malini Basu · 2024 · Life Sciences
  92. Inhibition of PCSK9: A Promising Enhancer for Anti-PD-1/PD-L1 Immunotherapy
    Shengbo Sun, Jingxin Ma, Tingting Zuo, Jinyao Shi, Liting Sun, Cong Meng, Wenlong Shu, Zhengyang Yang, Hongwei Yao, Zhongtao Zhang · 2024 · Research
  93. Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export
    Hoon Choi, Mamta Gupta, Arjun Sengupta, Emma Elizabeth Furth, Christopher Hensley, Aalim M. Weljie, Hsiaoju S. Lee, Yuting Lu, Austin Pantel, David A. Mankoff et al. · 2025 · Neoplasia
  94. Signaling pathway dysregulation in breast cancer
    Dinara Ryspayeva, Attila A. Seyhan, William MacDonald, Connor Purcell, Tyler J. Roady, Maryam Ghandali, Nataliia Verovkina, Wafik S. El‐Deiry, Martin S. Taylor, Stephanie L. Graff · 2025 · Oncotarget
  95. Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of squamous cell carcinoma of the head and neck
    Gabrielle van Caloen, Jean‐Pascal Machiels · 2019 · Current Opinion in Oncology
  96. Network rewiring, adaptive resistance and combating strategies in breast cancer
    Constance Gaya Cremers, Lan K. Nguyen · 2019 · Cancer Drug Resistance
  97. Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma
    Ning Qu, Xiao Hua SHI, Jingjing Zhao, Haixia Guan, Tingting Zhang, Shishuai Wen, Tian Liao, Jia‐Qian Hu, Wei-Yan Liu, Yulong Wang et al. · 2020 · Thyroid
  98. Bayesian Structure Learning in Multilayered Genomic Networks
    Min Jin Ha, Francesco C. Stingo, Veerabhadran Baladandayuthapani · 2020 · Journal of the American Statistical Association
  99. Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma
    Maria‐Filothei Lazaridou, Chiara Massa, Diana Handke, Anja Müeller, Michael Friedrich, Karthikeyan Subbarayan, Sandy Tretbar, Reinhard Dummer, Peter Koelblinger, Barbara Seliger · 2020 · Journal of Clinical Medicine
  100. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies
    Zachary S. Dovey, Sujit S. Nair, Dimple Chakravarty, Ashutosh Kumar Tewari · 2021 · Cancer Reports